Position
Squarepoint Ops LLC in Halozyme Therapeutics, Inc.
Back to the book · All holders of HALO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$166.3K$67.30 → $64.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 413.5K | $27.8M | — | — | — | 0.0% |
| Q1 2026 | 62.3K | $4.03M | $64.63 | −$166.3K | −$23.6M | 0.0% |